论文部分内容阅读
目的分析研究新生儿黄疸通过茵栀黄联合微生态制剂治疗的方法、治疗效果,为临床提供依据。方法选取2013年1月至2015年1月128例新生儿黄疸患者的临床资料实施回顾性分析,将其随机分为观察组和对照组,每组64例,对照组通过常规治疗方法进行治疗,观察组在常规治疗的基础之上给予口服茵栀黄口服液和微生态制剂妈咪爱进行治疗,比较观察组和对照组患者的治疗有效率、不良反应、治疗后两组患者血清总胆红素的改变情况,将结果进行统计学分析。结果观察组治疗有效率明显高于对照组,差异有统计学意义(P<0.05);观察组治疗后第7天血清胆红素水平明显低于对照组,差异有统计学意义(P<0.05);两组均未出现严重不良反应。结论针对新生儿黄疸患者通过茵栀黄联合微生态制剂进行治疗的效果显著,患者未出现不良反应,能够成为治疗新生儿高胆红素血症的辅助用药。
Objective To analyze and study neonatal jaundice by Yinzhihuang combined with probiotics treatment, the therapeutic effect, provide the basis for clinical. Methods The clinical data of 128 neonates with jaundice from January 2013 to January 2015 were retrospectively analyzed. They were randomly divided into observation group and control group, with 64 cases in each group. The control group was treated by routine treatment, The observation group was given oral Yinzhihuang oral solution and probiotics mommy on the basis of routine treatment. The treatment efficiency and adverse reactions in the observation group and the control group were compared. After treatment, the serum total bilirubin Changes in the prime, the results for statistical analysis. Results The effective rate of observation group was significantly higher than that of control group (P <0.05), and the level of serum bilirubin in observation group was significantly lower than that of control group on the 7th day (P <0.05) ); No serious side effects occurred in both groups. Conclusion Neonatal jaundice patients treated with Yinzhihuang combined with probiotics are effective in treating neonatal jaundice patients without side effects and can be an adjuvant for the treatment of neonatal hyperbilirubinemia.